EGFR and prostate carcinoma: More recently, we provided evidence that the epidermal growth factor receptor (EGFR) signalling pathway is implicated as an early event that constitutively activates the PI3K/Akt/NF-κB pathway in PC-3 prostate cancer cells (Le Page et al, 2005b).